Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
305.8 USD | -0.22% | -2.12% | +6.19% |
22/05 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
22/05 | Roche Gets US FDA Breakthrough Designation For Lipoprotein(a) Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.19% | 16TCr | |
+38.51% | 73TCr | |
+33.05% | 60TCr | |
-6.23% | 35TCr | |
+18.78% | 33TCr | |
+1.35% | 28TCr | |
+16.00% | 24TCr | |
+8.09% | 20TCr | |
-5.77% | 20TCr | |
+0.31% | 16TCr |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- RBC Lifts Price Target on Amgen to $224 From $223, Maintains Sector Perform Rating